Journal of Turkish Clinical Biochemistry

The official publication of Turkish Society of Clinical Biochemistry

Diamond OA
No APCs
First Decision
30 Days
Indexed In
TR Dizin
Original Research
April 01, 2004
JTCB. 2004 Apr 1; 2 (1) : 001-007

The Effects of Propylthyouracil Therapy on the Nitric Oxide, Oxidants, Antioxidants in the Hyperthyroidic Patients

1 Kocaeli Üniversitesi Tıp Fakültesi Biyokimya Anabilim Dalı, Kocaeli
2 Kocaeli Üniversitesi Tıp Fakültesi Dahiliye Anabilim Dalı, Kocaeli
3 Kocaeli Üniversitesi Tıp Fakültesi Halk Sağlığı Anabilim Dalı, Kocaeli
4 Central Hospital Kardiyoloji Ünitesi, Kocaeli

Abstract

Aim: The oxidative stress which is caused by free radicals can play role in emerging and/or progressing many diseases. Hyperthyroidism can induce a lot of changes dealing with the systems of nitric oxide (NO) and antioxidant systems of several tissues in increasing the production of free radicals. The aim of this study is to investigate the changes of NO, malondialdehyde (MDA), glutathione (GSH) and glutathione peroxidase (GSH-Px) in the hyperthyroidic patients who have been treated with propylthiouracil (PTU).

Materials and Methods: According to this aim the NO, MDA, GSH and GSH-Px levels are determined in the just diagnosed 21 patients before and after PTU treatment. Same parameters were investigated in the control group consisting of 20 healthy individuals.

Results: While the free triiodothyronine (FT3), free thyroxine (FT4), NO, MDA levels of patient group before PTU treatment were found to be significantly higher than those of control group (Student's T test, p<0.001), GSH levels were found to be lower (Student's T test, p<0.05). Patient group's GSH-Px and GSH levels after PTU treatment were found to be higher than those before treatment and NO and MDA levels were found to be lower after treatment (Student's T test, respectively p<0.005, p<0.001, p<0.005, p<0.005).When the FT3 and GSH-Px levels of patients after treatment were compared with those of control group, it has been found out, that GSH-Px levels of patients have increased and FT3 levels were still higher than those of control group (Student's T test, both p<0,001). After PTU therapy, the FT4, NO and MDA levels of patient group were not significantly different from those of control group (Student's T test, p>0.05), and GSH levels were still lower (Student's T test, p<0.001).

Conclusion: The findings of our study has shown that hyperthyroidism deteriorates the balance in the oxidant-antioxidant system in favour of oxidants. PTU therapy tries to correct this. The changes of NO during these interactions let us consider that NO is related to the pathophysiology and possibly to the therapy of the disease.

Citation

Yalçın, Berna, Can Duman, Mustafa B. Çekmen, Berrin Çetinarslan, Zeynep Cantürk, Sarper Erdoğan, Hacı Kahya Özdoğan, İstemihan Tengiz, and Ertuğrul Ercan. 2004. “The Effects of Propylthyouracil Therapy on the Nitric Oxide, Oxidants, Antioxidants in the Hyperthyroidic Patients”. Journal of Turkish Clinical Biochemistry 2 (1):001-007. https://turkclinbiochem.org/index.php/pub/article/view/23.

Publish with JTCB

Diamond Open Access

Fully Diamond OA with no APCs and no submission fees. Your research is freely available to readers worldwide from the day it publishes.

30-Day First Decision

Double-blind peer review from an active editorial team returns a first decision in about 30 days, keeping your manuscript moving.

Global Platform

Backed by the Turkish Society of Clinical Biochemistry, JTCB welcomes submissions from researchers worldwide and reaches an international laboratory audience.

Focused Laboratory Scope

Method validation, analyzer comparisons, reference intervals, quality indicators, preanalytical studies, and instructive clinical case reports.

Credible and Discoverable

All manuscripts publish in English and follow ICMJE and COPE guidelines, with Crossref DOIs and TR Dizin indexing ensuring global discoverability.